Varian Medical Systems

Varian Medical Systems, headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.

PALO ALTO, Calif.--(BUSINESS WIRE)-- #VARIAN--Varian's RapidArc Dynamic Solution Unlocks New Dimensions in Treatment Planning and Delivery.

Varian's RapidArc Dynamic Solution Unlocks New Dimensions in Treatment Planning and Delivery

PALO ALTO, Calif.--(BUSINESS WIRE)-- #VARIAN--Varian, a Siemens Healthineers company, announced a 10-year agreement with Ballad Health, to bring advanced oncology treatment services to serve patients in rural communities across the Appalachian Highlands in Northeast Tennessee, Southwest Virginia, northwestern North Carolina, and southeastern Kentucky. The transformational oncology collaboration with the Johnson City, Tennessee-based health system, is designed to deliver advanced treatment technology thro.

Varian Announces 10-year Transformational Oncology Collaboration with Ballad Health to Bring Advanced Treatment Solutions to Rural Communities

Palo Alto, California, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Varian, a Siemens Healthineers company, today announced the launch of HyperSight™ imaging solution for its TrueBeam and Edge systems across the Asia Pacific region (excluding China). This upgrade gives clinicians unparalleled image quality, enhancing their ability to deliver precise and efficient radiation therapy treatments. HyperSight optimizes workflows across Varian's entire suite of linear accelerators, enabling more tailored treatment for each patient.

Varian Launches HyperSight™ for TrueBeam in Asia Pacific: Boosting Accuracy and Efficiency in Radiotherapy Treatment

Siemens Healthineers AG

German medical equipment maker Siemens Healthineers on Thursday posted first-quarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit Varian.

Siemens Healthineers Q1 sales beat expectations on strong Varian unit

Shares in Siemens Healthineers rose on Wednesday after the German health group said it expected its newly-acquired Varian business to grow faster than other divisions in the coming three years, boosting the group's revenue.

Siemens Healthineers bets on Varian to boost growth

PALO ALTO, Calif., April 27, 2021 /PRNewswire/ -- Varian (NYSE: VAR), a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing global cancer burden.

Varian and Icon Group Partner to Extend Commitment to Global Cancer Care

Lattice Semiconductor

Progyny

S&P Global

Tyler Technologies

Domtar

NEW YORK, April 15, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20: S&P MidCap 400 constituent PTC Inc. (NASD:PTC) will replace Varian Medical Systems Inc. (NYSE:VAR) in the S&P 500, and Lattice Semiconductor Co. (NASD:LSCC) will replace PTC in the S&P MidCap 400. Siemens Healthineers AG (XETR: SHL) acquired Varian Medical Systems Inc. in a deal that closed today, April 15.

PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600

PALO ALTO, Calif., April 12, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row.

Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year

Varian (VAR) partners with Google Cloud to help in the fight against cancer through the development of an advanced AI based diagnostic platform.

Varian (VAR) Inks Deal With Google Cloud to Boost Cancer Care

PALO ALTO, Calif., April 8, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer.

Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer

Varian Medical (VAR) is optimistic about its prospective acquisitions and strength in Proton Therapy segment.

Varian Medical (VAR) Hits 52-Week High: What's Driving It?

PALO ALTO, Calif. and PETACH TIKVA, Israel, March 25, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced a new investment in Bend It Technologies Ltd.

Varian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable Microcatheters

Investor optimism is high on the Varian (VAR) stock, courtesy of its solid prospects.

Why You Should Retain Varian (VAR) in Your Portfolio Now

PALO ALTO, Calif., Feb. 24, 2021 /PRNewswire/ -- CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a Texas-based health system, to provide a...

CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health

EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers' $16.4-billion bid for U.S. peer Varian Medical Systems Inc, three people familiar with the matter said.

Exclusive: EU antitrust regulators to okay Siemens Healthineers' $16.4 billion Varian buy - sources

PALO ALTO, Calif., Feb. 4, 2021 /PRNewswire/ -- Varian (NYSE: VAR) has started the installation of the cyclotron and gantry for its ProBeam® 360° single-room proton therapy system at Penn Medicine Lancaster General Health's Ann B. Barshinger Cancer Institute. The cyclotron and gantry are...

Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health

Varian's (VAR) receipt of 13 Ethos orders in fiscal Q1 raises investors' optimism on the stock.

Varian (VAR) Q1 Earnings Beat Estimates, Revenues Miss Mark

Varian Medical Systems, Inc. (VAR) delivered earnings and revenue surprises of 9.62% and -8.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Varian Medical Systems, Inc. (VAR) Beats Q1 Earnings Estimates

Varian's (VAR) fiscal first-quarter earnings are likely to reflect strength in Halcyon platform.

Varian (VAR) to Report Q1 Earnings: What's in the Offing?

PALO ALTO, Calif., Jan. 19, 2021 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as the leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in all nine of the tracked categories. Additionally, Varian's Net Promotor Score (NPS) improved from...

Varian Ranked Highest in Survey of US Radiation Oncology Professionals

PALO ALTO, Calif., Jan. 8, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced its first quarter fiscal year 2021 earnings release date. The Company will report results for the first quarter of fiscal year 2021 after market close on Tuesday, January 26, 2021. In light of the pending...

Varian Announces First Quarter Fiscal Year 2021 Earnings Release Date

Varian (VAR) will be coordinating with Yonsei Cancer Center on formulating AI solutions, which are proven to upgrade early detection of cancer.

Varian (VAR) Inks Deal With Yonsei Cancer Center in Korea

Investor confidence is high on Varian Medical (VAR) stock, courtesy of solid prospects.

Here's Why You Should Hold onto Varian Medical (VAR) Stock Now

Varian Medical Systems has key drivers in the growth engine that will continue to generate torque to the flywheel. The Siemens transaction highlights the company's standing as a leading authority in stereotactic surgery and radiation-type therapy, with a $16.4 billion dollar valuation.

Varian Medical Systems: Key Upside Factors To The Siemens Transaction

PALO ALTO, Calif., and CINCINNATI, Ohio, Nov. 19, 2020 /PRNewswire/ -- Varian (NYSE: VAR) and the Cincinnati Children's/UC Health Proton Therapy Center today announce the start of the first clinical trial of FLASH therapy as part of the recently opened FAST-01 study (FeAsibility Study of...

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Announce Initial Patient Treated in the FAST-01 First Human Clinical Trial of FLASH Therapy for Cancer

News for Varian Medical Systems Stock (VAR)